Technology
Flotek Surpasses 2024 Annual Guidance with Strong Fourth Quarter and Full-Year Results
Published
1 week agoon
By

HOUSTON, March 10, 2025 /PRNewswire/ — Flotek Industries, Inc. (“Flotek” or the “Company”) (NYSE: FTK) today announced operational and financial results for the fourth quarter and full-year ended December 31, 2024. Fourth quarter 2024 results were the strongest quarterly results of 2024 in terms of revenue, gross profit, net income and adjusted EBITDA (1).
Financial Summary (in thousands, except ‘per share’ amounts)
Three Months Ended
December 31,
Twelve Months Ended
December 31,
2024
2023
2024
2023
Total Revenues
$ 50,758
$ 42,188
$ 187,025
$ 188,058
Gross Profit
$ 12,277
$ 9,430
$ 39,386
$ 24,263
Net Income
$ 4,429
$ 2,104
$ 10,498
$ 24,713
Diluted Income (Loss) Per Share
$ 0.14
$ 0.07
$ 0.34
$ (0.10)
Adjusted EBITDA (1)
$ 7,023
$ 3,952
$ 20,327
$ 1,488
Full-Year and Fourth Quarter 2024 Highlights
Q4 2024 total revenue rose 20% vs. Q4 2023, led by a 21% jump in external customer revenue—the highest in 5 years.Data analytics service revenue grew 124% vs. Q4 2023 and 44% vs. full year 2023.Gross profit climbed 30% vs. Q4 2023 and 62% vs. full year 2023, with Q4 2024 gross margin rising to 24%.Q4 2024 net income was $4.4 million and adjusted EBITDA(1) totaled $7.0 million, up 111% and 78%, respectively, vs Q4 2023.2024 net income hit $10.5 million or $0.34/share, vs. a loss of $(0.10)/share in 2023.2024 adjusted EBITDA(1) reached $20.3 million, up $18.8 million from 2023—the highest since 2017—exceeding guidance of $18.5 million by 10%.
Management Commentary
Chief Executive Officer Dr. Ryan Ezell commented, “2024 marks a significant step in the execution of our corporate strategy towards the convergence between innovative Data and Chemistry solutions that deliver outstanding value to our customers and external stakeholders. This year, we not only achieved the highest profitability metrics in nearly a decade but did so through superior operational efficiency and service quality execution. Additionally, our commitment to safety has shone through, with no lost-time incidents recorded in the past three years.
We’ve expanded our technology portfolio with the introduction of three cutting-edge Data Analytics solutions: VeraCal, JP3 Raman, and XSPCT, systems specifically designed to address the unique challenges of the energy and infrastructure sector while driving high-margin growth into 2025 and beyond. In the fourth quarter, we observed a significant transformation in our Data Analytics revenue resulting in a 67% sequential increase in service revenue furthering the shift from products to services.
Looking ahead, we expect that the integration of Data and Chemistry at Flotek will provide exciting new innovations in the energy and infrastructure market. These advancements are set to empower our customers’ assets to maximize returns, reduce costs, automate processes, and leverage data in ways previously unimaginable. We believe that our relentless pursuit to leverage chemistry as the common value creation platform will position Flotek as a leader in differentiated technologies and foster our future growth.”
Fourth Quarter and Full-Year 2024 Financial Results
Revenue: Flotek reported total revenues of $50.8 million for fourth quarter 2024, an increase of $8.6 million, or 20%, compared to total revenues of $42.2 million for fourth quarter 2023. Full-year 2024 total revenues totaled $187.0 million, as compared to total revenues of $188.1 million during 2023. Fourth quarter and full year 2024 revenues include $8.6 million and $32.4 million, respectively, related to the minimum purchase requirements under the Company’s long-term supply agreement with ProFrac Services, LLC.
Segment Revenue Summary (in thousands)
Three Months Ended
December 31,
Twelve Months Ended
December 31,
2024
2023
2024
2023
Chemistry Technologies:
External Revenues
$ 21,071
$ 17,996
$ 63,214
$ 59,016
Related Party Revenues
27,215
22,769
114,947
120,903
Total
$ 48,286
$ 40,765
$ 178,161
$ 179,919
Data Analytics:
Product Revenues
$ 826
$ 688
$ 4,745
$ 5,277
Service Revenues
1,646
735
4,119
2,862
Total
$ 2,472
$ 1,423
$ 8,864
$ 8,139
Gross Profit: The Company generated gross profit of $12.3 million during fourth quarter 2024 compared to a gross profit of $9.4 million during fourth quarter 2023. The improvement in fourth quarter 2024 gross profit was primarily the result of successful initiatives throughout 2024 to drive cost reductions with respect to freight, logistics and materials combined with an 18% increase in chemistry revenue and a 74% increase in data analytics revenue, as compared to fourth quarter 2023.
The Company generated gross profit of $39.4 million for full-year 2024 compared to gross profit of $24.3 million for full-year 2023.Selling, General and Administrative (“SG&A”) Expense: SG&A expense totaled $6.6 million for the fourth quarters of 2024 and 2023. SG&A expense totaled $24.7 million for full-year 2024 compared to $27.8 million for full-year 2023, an 11% reduction year-over-year. Excluding non-cash stock compensation expense, 2024 SG&A expense is 17% lower than 2023.Net Income (Loss) and EPS: Flotek reported net income of $4.4 million, or $0.14 per diluted share, for the fourth quarter 2024. This compares to net income of $2.1 million, or $0.07 per diluted share, for the fourth quarter 2023. Net income for full-year 2024 was $10.5 million, or $0.34 per diluted share, compared to net income (loss) of $24.7 million, or ($0.10) per diluted share, for the comparable period of 2023. Net income for full-year 2023 included non-cash gains related to the fair value measurement of convertible notes payable and a PPP loan forgiveness totaling $34.5 million.Adjusted EBITDA (Non-GAAP)(1): Adjusted EBITDA(1) was $7.0 million in fourth quarter 2024 as compared to $4.0 million in fourth quarter 2023. Adjusted EBITDA(1) was $20.3 million for full-year 2024 compared to $1.5 million for full-year 2023.
(1)
See the “Unaudited Reconciliation of Non-GAAP Items and Non-Cash Items Impacting Earnings” section in this release for more information, including reconciliations to the most comparable GAAP measures.
2025 Guidance
Consistent with 2024 and 2023, Flotek plans to issue 2025 guidance in conjunction with the release of its first quarter 2025 financial and operating results.
Upcoming Investor Event
Flotek will participate in the 37th Annual Roth Conference to be held at the Marriott in Laguna Dana Point, California, March 17-18, 2025. Flotek Chief Executive Officer, Ryan Ezell, will participate in an industry panel discussion on March 17 at 10:00 a.m. PT and will be joined by Chief Financial Officer, Bond Clement, in hosting one-on-one meetings during the event. An updated corporate presentation to be used in discussions at the conference will be posted to the Investor Relations section of Flotek’s corporate website at www.flotekind.com prior to the start of the conference.
Conference Call Details
Flotek will host a conference call on March 11, 2025, at 9:00 a.m. CT (10:00 a.m. ET) to discuss its fourth quarter and full-year 2024 results. Participants may access the call through Flotek’s website at www.flotekind.com under “News” within the Investor Relations section, by telephone toll free at 1-800-836-8184 (international toll: 1-646-357-8785), or by using the following link to access the audience view of the webcast at https://app.webinar.net/qDjWg9qga1Y approximately five minutes prior to the start of the call. Following the conclusion of the conference call, a recording of the call will be available on the Company’s website.
An updated corporate presentation that will be referenced on the call will be posted to the Investor Relations section of Flotek’s website at www.flotekind.com prior to the start of the earnings conference call.
About Flotek Industries, Inc.
Flotek Industries, Inc. is a leading chemistry and data technology company focused on servicing the Energy industry. The Company’s top tier technologies leverage near real-time data to deliver innovative solutions to maximize customer returns. Flotek has an intellectual property portfolio of over 130 patents, 20+ years of field and laboratory data, and a global presence in more than 59 countries.
Flotek has established collaborative partnerships focused on sustainable and optimized chemistry and data solutions, aiming to reduce the environmental impact of energy on land, air, water and people.
Flotek is based in Houston, Texas and its common shares are traded on the New York Stock Exchange under the ticker symbol “FTK.” For additional information, please visit www.flotekind.com.
Forward-Looking Statements
Certain statements set forth in this press release constitute forward-looking statements (within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934) regarding Flotek Industries, Inc.’s business, financial condition, results of operations and prospects. Words such as will, continue, expects, anticipates, intends, plans, believes, seeks, estimates and similar expressions or variations of such words are intended to identify forward-looking statements, but are not the exclusive means of identifying forward-looking statements in this press release. Although forward-looking statements in this press release reflect the good faith judgment of management, such statements can only be based on facts and factors currently known to management. Consequently, forward-looking statements are inherently subject to risks and uncertainties, and actual results and outcomes may differ materially from the results and outcomes discussed in the forward-looking statements. Further information about the risks and uncertainties that may impact the Company are set forth in the Company’s most recent filing with the Securities and Exchange Commission on Form 10-K (including, without limitation, in the “Risk Factors” section thereof), and in the Company’s other SEC filings and publicly available documents. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company undertakes no obligation to revise or update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this press release.
FLOTEK INDUSTRIES, INC.
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except share data)
December 31, 2024
December 31, 2023
ASSETS
Current assets:
Cash and cash equivalents
$ 4,404
$ 5,851
Restricted cash
102
102
Accounts receivable, net of allowance for credit losses of $447 and $745 at
December 31, 2024 and December 31, 2023, respectively
17,386
13,687
Accounts receivable, related party, net of allowance for credit losses of $0 at
each of December 31, 2024 and December 31, 2023, respectively
52,370
34,569
Inventories, net
13,303
12,838
Other current assets
2,952
3,564
Current contract asset
5,939
5,836
Total current assets
96,456
76,447
Long-term contract asset
63,105
68,820
Property and equipment, net
6,178
5,129
Operating lease right-of-use assets
3,326
5,030
Deferred tax assets, net
51
300
Other long-term assets
1,680
1,787
TOTAL ASSETS
$ 170,796
$ 157,513
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable
$ 38,073
$ 31,705
Accrued liabilities
5,912
5,890
Income taxes payable
48
45
Current portion of operating lease liabilities
1,486
2,449
Current portion of finance lease liabilities
—
22
Asset-based loan
4,789
7,492
Current portion of long-term debt
60
179
Total current liabilities
50,368
47,782
Deferred revenue, long-term
14
35
Long-term operating lease liabilities
6,514
7,676
Long-term debt
—
60
TOTAL LIABILITIES
56,896
55,553
Commitments and contingencies
Stockholders’ equity:
Preferred stock, $0.0001 par value, 100,000 shares authorized; no shares
issued and outstanding
—
—
Common stock, $0.0001 par value, 240,000,000 shares authorized;
30,938,073 shares issued and 29,826,508 shares outstanding at
December 31, 2024; 30,772,837 shares issued and 29,664,130 shares
outstanding at December 31, 2023
3
3
Additional paid-in capital
464,620
463,140
Accumulated other comprehensive income
251
127
Accumulated deficit
(316,308)
(326,806)
Treasury stock, at cost; 1,111,565 and 1,108,707 shares at December 31,
2024 and December 31, 2023, respectively
(34,666)
(34,504)
Total stockholders’ equity
113,900
101,960
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY
$ 170,796
$ 157,513
FLOTEK INDUSTRIES, INC.
Unaudited Condensed Consolidated Statements of Operations
(in thousands, except per share data)
Three Months Ended
December 31,
Twelve Months Ended
December 31,
2024
2023
2024
2023
Revenue:
Revenue from external customers
$ 23,328
$ 19,239
$ 71,263
$ 66,518
Revenue from related party
27,430
22,949
115,762
121,540
Total revenues
50,758
42,188
187,025
188,058
Cost of goods sold
38,481
32,758
147,639
163,795
Gross profit
12,277
9,430
39,386
24,263
Operating costs and expenses:
Selling, general, and administrative
6,630
6,552
24,709
27,827
Depreciation
229
204
891
734
Research and development
365
255
1,714
2,486
Gain on sale of property and equipment
(90)
—
(124)
(38)
Gain in fair value of Contract Consideration
Convertible Notes Payable
—
—
—
(29,969)
Total operating costs and expenses
7,134
7,011
27,190
1,040
Income from operations
5,143
2,419
12,196
23,223
Other income (expense):
Paycheck protection plan loan forgiveness
—
—
—
4,522
Interest expense
(253)
(320)
(1,095)
(2,857)
Other income (expense), net
(105)
56
46
(26)
Total other (expense) income
(358)
(264)
(1,049)
1,639
Income before income taxes
4,785
2,155
11,147
24,862
Income tax expense
(356)
(51)
(649)
(149)
Net income
$ 4,429
$ 2,104
$ 10,498
$ 24,713
Income (loss) per common share:
Basic
$ 0.15
$ 0.07
$ 0.36
$ 1.00
Diluted
$ 0.14
$ 0.07
$ 0.34
$ (0.10)
Weighted average common shares:
Weighted average common shares used in
computing basic income (loss) per common
share
29,642
29,396
29,534
24,830
Weighted average common shares used in
computing diluted income (loss) per common
share
31,436
30,496
30,889
28,377
FLOTEK INDUSTRIES, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
Twelve Months Ended
December 31,
2024
2023
Cash flows from operating activities:
Net income
$ 10,498
$ 24,713
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Change in fair value of contingent consideration
71
(527)
Change in fair value of Contract Consideration Convertible Notes Payable
—
(29,969)
Amortization of convertible note issuance costs
—
83
Payment-in-kind interest expense
—
2,284
Amortization of contract asset
5,612
5,033
Depreciation
891
734
Amortization of asset-based loan origination costs
314
121
Provision for credit losses, net of recoveries
181
138
Provision for excess and obsolete inventory
645
959
Gain on sale of property and equipment
(124)
(38)
Non-cash lease expense
2,094
3,014
Stock compensation expense
1,366
(254)
Deferred income tax expense
249
104
Paycheck protection plan loan forgiveness
—
(4,522)
Changes in current assets and liabilities:
Accounts receivable
(3,880)
5,311
Accounts receivable, related party
(17,801)
(11,886)
Inventories
(1,110)
1,938
Income taxes receivable
8
—
Other assets
561
(836)
Accounts payable
6,368
(1,670)
Accrued liabilities
(70)
(2,575)
Operating lease liabilities
(2,515)
(3,391)
Income taxes payable
3
(53)
Interest payable
—
(8)
Net cash provided by (used in) operating activities
3,361
(11,297)
FLOTEK INDUSTRIES, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
(continued)
Twelve Months Ended
December 31,
2024
2023
Cash flows from investing activities:
Capital expenditures
(1,940)
(1,081)
Proceeds from sale of assets
124
67
Net cash used in investing activities
(1,816)
(1,014)
Cash flows from financing activities:
Payment for forfeited stock options
—
(617)
Payments on long term debt
(179)
(149)
Proceeds from asset-based loan
166,950
68,716
Payments on asset-based loan
(169,653)
(61,224)
Payment of asset-based loan origination costs
(164)
(574)
Payments to tax authorities for shares withheld from employees
(162)
(268)
Proceeds from issuance of stock under Employee Stock Purchase Plan
114
77
Payments for finance leases
(22)
(33)
Net cash (used in) provided by financing activities
(3,116)
5,928
Effect of changes in exchange rates on cash and cash equivalents
124
(54)
Net change in cash and cash equivalents and restricted cash
(1,447)
(6,437)
Cash and cash equivalents at the beginning of period
5,851
12,290
Restricted cash at the beginning of period
102
100
Cash and cash equivalents and restricted cash at beginning of period
5,953
12,390
Cash and cash equivalents at end of period
4,404
5,851
Restricted cash at the end of period
102
102
Cash and cash equivalents and restricted cash at end of period
$ 4,506
$ 5,953
FLOTEK INDUSTRIES, INC.
Unaudited Reconciliation of Non-GAAP Items and Non-Cash Items Impacting Earnings
(in thousands)
Three Months Ended
December 31,
Twelve Months Ended
December 31,
2024
2023
2024
2023
Gross profit
$ 12,277
$ 9,430
$ 39,386
$ 24,263
Stock compensation expense
15
3
24
(132)
Severance and retirement
2
3
11
29
Contingent liability revaluation
117
(143)
71
(527)
Amortization of contract asset
1,271
1,368
5,612
5,033
Adjusted Gross profit (Non-GAAP) (1)
$ 13,682
$ 10,661
$ 45,104
$ 28,666
Net income
$ 4,429
$ 2,104
$ 10,498
$ 24,713
Interest expense
253
320
1,095
2,857
Income tax expense
356
51
649
149
Depreciation and amortization
229
204
891
734
EBITDA (Non-GAAP) (1)
$ 5,267
$ 2,679
$ 13,133
$ 28,453
Stock compensation expense
451
307
1,366
(268)
Severance and retirement
7
10
39
(17)
Contingent liability revaluation
117
(143)
71
(527)
Gain on disposal of assets
(90)
—
(124)
(38)
PPP loan forgiveness
—
—
—
(4,522)
Contract Consideration Convertible Notes Payable revaluation adjustment
—
—
—
(29,969)
Amortization of contract asset
1,271
1,368
5,612
5,033
Non-Recurring professional fees
—
(269)
230
3,343
Adjusted EBITDA (Non-GAAP) (1)
$ 7,023
$ 3,952
$ 20,327
$ 1,488
(1)
Management believes that adjusted gross profit, EBITDA and adjusted EBITDA for the three and twelve months ended December 31, 2024 and 2023, are useful to investors to assess and understand operating performance, especially when comparing those results with previous and subsequent periods. Management views the income and expenses noted above to be outside of the Company’s normal operating results. Management analyzes operating results without the impact of the above items as an indicator of performance, to identify underlying trends in the business and cash flow from continuing operations, and to establish financial and operational goals, excluding certain non-cash or non-recurring items.
View original content to download multimedia:https://www.prnewswire.com/news-releases/flotek-surpasses-2024-annual-guidance-with-strong-fourth-quarter-and-full-year-results-302397404.html
SOURCE Flotek Industries, Inc.
You may like
Technology
QUAD GmbH Expands Its Technology Offerings and Relationship with Vuzix with Follow-on Six-figure Smart Glasses Order
Published
20 minutes agoon
March 19, 2025By

ROCHESTER, N.Y., March 19, 2025 /PRNewswire/ — Vuzix® Corporation (NASDAQ: VUZI), (“Vuzix” or, the “Company”), a leading supplier of AI-powered Smart glasses, waveguides and Augmented Reality (AR) technologies, today announced that the Company has received and shipped against a follow-on six-figure smart glasses order from QUAD GmbH (“QUAD”), a leading distributor and consulting company in the areas of Auto-ID, Transport, Logistics and OEM Integration. QUAD’s newly formed QUAD Advanced Systems division provides full scale services and support for Vuzix products to its customers throughout Europe, focusing on the field service, manufacturing, security, warehouse and logistics and healthcare market verticals.
QUAD Advanced Systems, which consolidates its previous auto ID, transport, logistics and OEM divisions under one roof, will provide comprehensive support throughout the product lifecycle. Their deep technical knowledge of Vuzix smart glasses extends to real-world applications, including remote monitoring and operations assistance, warehousing logistics, and medical field innovations, where AR technology enhances operational precision and efficiency. QUAD’s expertise enables tailored solutions, such as optimizing smart glasses for inventory management, remote expert collaboration, or surgical support. To accelerate decision-making, QUAD facilitates rapid online demos, allowing clients to experience Vuzix technology virtually, followed by personalized guidance to connect with the best-fit reseller for their industry-specific needs.
“QUAD prides itself in investing in the future, and partnering with Vuzix ensures that we continue that tradition of providing truly state-of-the-art solutions for our customers,” said Andreas Wey, CEO of QUAD GmbH. “Operational efficiency is a real differentiator, and nothing encapsulates that more than the use of AR technology enabled through the use of smart glasses. We are absolutely delighted to both offer and support the Vuzix product range across our core vertical markets.”
“We are excited to be expanding our relationship with QUAD, who has built a strong reputation as a premier European distributor of technology and consulting services over the past 30 years,” said Paul Travers, President and CEO of Vuzix. “QUAD’s hands-on approach in sectors like healthcare and warehousing, combined with its ability to troubleshoot real-time challenges, underscores its role as a valued Vuzix partner.”
About Vuzix Corporation
Vuzix is a leading designer, manufacturer and marketer of AI-powered Smart Glasses, Waveguides and Augmented Reality (AR) technologies, components and products for the enterprise, medical, defense and consumer markets. The Company’s products include head-mounted smart personal display and wearable computing devices that offer users a portable high-quality viewing experience, provide solutions for mobility, wearable displays and augmented reality, as well OEM waveguide optical components and display engines. Vuzix holds more than 425 patents and patents pending and numerous IP licenses in the fields of optics, head-mounted displays, and the augmented reality wearables field. The Company has won Consumer Electronics Show (or CES) awards for innovation for the years 2005 to 2024 and several wireless technology innovation awards among others. Founded in 1997, Vuzix is a public company (NASDAQ: VUZI) with offices in: Rochester, NY; and Kyoto and Okayama, Japan. For more information, visit the Vuzix website, Twitter and Facebook pages.
Forward-Looking Statements Disclaimer
Certain statements contained in this news release are “forward-looking statements” within the meaning of the Securities Litigation Reform Act of 1995 and applicable Canadian securities laws. Forward looking statements contained in this release relate to Vuzix Smart Glasses, our business relationship and future opportunities with QUAD GmbH and its customers, and among other things the Company’s leadership in the Smart Glasses and AR display industry. They are generally identified by words such as “believes,” “may,” “expects,” “anticipates,” “should” and similar expressions. Readers should not place undue reliance on such forward-looking statements, which are based upon the Company’s beliefs and assumptions as of the date of this release. The Company’s actual results could differ materially due to risk factors and other items described in more detail in the “Risk Factors” section of the Company’s Annual Reports and MD&A filed with the United States Securities and Exchange Commission and applicable Canadian securities regulators (copies of which may be obtained at www.sedar.com or www.sec.gov). Subsequent events and developments may cause these forward-looking statements to change. The Company specifically disclaims any obligation or intention to update or revise these forward-looking statements as a result of changed events or circumstances that occur after the date of this release, except as required by applicable law.
Vuzix Media and Investor Relations Contact:
Ed McGregor, Director of Investor Relations,
Vuzix Corporation
ed_mcgregor@vuzix.com
Tel: (585) 359-5985
Vuzix Corporation, 25 Hendrix Road, West Henrietta, NY 14586 USA,
Investor Information – IR@vuzix.com www.vuzix.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/quad-gmbh-expands-its-technology-offerings-and-relationship-with-vuzix-with-follow-on-six-figure-smart-glasses-order-302405786.html
SOURCE Vuzix Corporation
Technology
China-Austria Economic and Trade Cooperation Forum and 3rd CISCE Promotion Held in Vienna
Published
20 minutes agoon
March 19, 2025By

VIENNA, March 19, 2025 /PRNewswire/ — The China-Austria Economic and Trade Cooperation Forum, in conjunction with a promotional event for the third China International Supply Chain Expo (“CISCE”), was held in Vienna, Austria. The gathering brought together over 200 representatives from trade and investment promotion agencies, business associations, and companies from both China and Austria. During the forum, China International Exhibition Center Group spotlighted the upcoming CISCE and inked cooperation agreements with key Austrian institutions and businesses.
Ren Hongbin, chairman of the China Council for the Promotion of International Trade (“CCPIT”), praised the recent progress in Sino-Austrian collaboration across multiple sectors. He highlighted China’s readiness to work closely with Austrian partners to leverage complementary strengths in resources and industrial frameworks. Ren also encouraged businesses from both nations to explore new opportunities for business expansion and invited Austrian businesses and institutions to participate in the 3rd CISCE.
The event was attended by Christoph Matznetter, Vice President of the Austrian Federal Economic Chamber, and Qi Mei, the Chinese Ambassador to Austria, among other prominent guests.
Austrian representative, noted that the forum represented the first significant economic and trade event between Austria and China since the inauguration of the new Austrian government, underscoring its crucial role in strengthening bilateral relations. He affirmed China as a reliable partner and lauded the CISCE as a leading exhibition dedicated to enhancing international industrial and supply chain cooperation. He also expressed optimism about broader cooperation to address global challenges and uphold international trade norms.
The China International Supply Chain Expo, recognized as the world’s premier national-level exhibition focused on supply chains, aims to facilitate integration across upstream, midstream, and downstream sectors, connect businesses of all sizes, encourage collaboration between industry, academia and research institutions, while enhancing interaction between Chinese and multinational businesses. Under the theme Connecting the World for a Shared Future, it has emerged as a crucial platform for bolstering international cooperation in industrial and supply chains. The 3rd CISCE will be held from July 16th to 20th in Beijing, with exhibition zones featuring Advanced Manufacturing, Clean Energy, Smart Vehicle and more, with over 300 companies already confirming their participation.
Earlier this year, the promotional events for CISCE were held in Germany, Switzerland, Portugal, and the UK to reinforce cooperative ties between China and European nations, broadening and deepening bilateral economic and trade relations.
Photo – https://mma.prnewswire.com/media/2645319/photo.jpg
Logo – https://mma.prnewswire.com/media/2427202/CISCE_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/china-austria-economic-and-trade-cooperation-forum-and-3rd-cisce-promotion-held-in-vienna-302405881.html
Technology
Alamar Biosciences Announces First Five Distribution Partners, Expanding Commercial Support in Asia Pacific
Published
20 minutes agoon
March 19, 2025By

FREMONT, Calif., March 19, 2025 /PRNewswire/ — Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, is pleased to announce the signing of five new distribution partners to expand its global presence. The company has partnered with established industry leaders across key international markets to enhance access to its innovative proteomics technologies.
The newly signed distribution partners include:
GeneWorks – Australia and New ZealandGenomax – SingaporePhileKorea – South KoreaScrum Inc. – JapanSpinco – India
“We are excited to welcome these outstanding partners to the Alamar network,” said Yuling Luo, Ph.D., Founder, Chairman and CEO of Alamar Biosciences, “Their deep expertise in the life sciences industry and strong regional presence will allow us to bring our next-generation proteomics solutions to more researchers and clinicians worldwide.”
Alamar’s technology empowers scientists to achieve groundbreaking insights in biomarker discovery, drug development, and disease research. Through these new partnerships, researchers in Asia-Pacific will now have enhanced access to Alamar’s cutting-edge platforms and technical support.
Alamar remains committed to supporting the scientific community with best-in-class tools that enable high-sensitivity protein analysis. For more information on Alamar’s distribution network and solutions, visit alamarbio.com.
About Alamar Biosciences, Inc.
Alamar Biosciences is a privately held life sciences company with a mission to power precision proteomics to enable the earliest detection of disease. The company’s proprietary NULISA™ Platform along with the ARGO™ HT System work seamlessly with the latest advances in genomics to achieve single digit attomolar detection sensitivity, greatly surpassing the most sensitive protein detection technology on the market today. For more information, please visit alamarbio.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/alamar-biosciences-announces-first-five-distribution-partners-expanding-commercial-support-in-asia-pacific-302405723.html
SOURCE Alamar Biosciences, Inc.


QUAD GmbH Expands Its Technology Offerings and Relationship with Vuzix with Follow-on Six-figure Smart Glasses Order

China-Austria Economic and Trade Cooperation Forum and 3rd CISCE Promotion Held in Vienna

Alamar Biosciences Announces First Five Distribution Partners, Expanding Commercial Support in Asia Pacific

Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network

New Gooseneck Omni Antennas Offer Enhanced Signals in a Durable Package

Huawei Launches Global City Intelligent Twins Architecture to Accelerate City Digital Transformation

Why You Should Build on #NEAR – Co-founder Illia Polosukhin at CV Labs

Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network

NEAR End of Year Town Hall 2021: The Open Web World, MetaBUILD 2 Hackathon and 2021 recap
Trending
-
Coin Market4 days ago
Kaito AI and founder Yu Hu's X social media accounts hacked
-
Coin Market3 days ago
Uber angel investor stirs Bitcoin debate with 'build a better Bitcoin' remark
-
Technology4 days ago
YupMD Revolutionizes Weight Loss with Cutting-Edge Telehealth Solutions
-
Technology4 days ago
Mitolyn Alerts Consumers About Misleading Third-Party Resellers and Reinforces Commitment to Product Integrity
-
Technology4 days ago
GRE Alpha to Showcase Innovative LED Driver Solutions with LumiFree™ Light Distribution Technology at LEDucation 2025
-
Technology5 days ago
The OpenSSL Corporation and The OpenSSL Foundation Announce the Formation of Technical Advisory Committees (TACs)
-
Technology5 days ago
CASEKOO: Explore The Luminous Enigma and Let the enchanting artistry of Tarot Ignite your Intuition and Enlightenment.
-
Coin Market4 days ago
Rising $219B stablecoin supply signals mid-bull cycle, not market top